Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Richard Isbrucker"'
Autor:
Peter B. Gilbert, Richard Isbrucker, Nick Andrews, David Goldblatt, Paul T. Heath, Alane Izu, Shabir A. Madhi, Lawrence Moulton, Stephanie J. Schrag, Nong Shang, George Siber, Ajoke Sobanjo-ter Meulen
Publikováno v:
Vaccine. 40:4283-4291
Autor:
Elliot Lilley, Emmanuelle Coppens, Pradip Das, Francis Galaway, Richard Isbrucker, Sarah Sheridan, Paul Stickings, Anthony Holmes
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization.
The UK National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) has been tasked by the World Health Organization (WHO) to review the extent to which animal-based testing methods are described in their manuals, gui
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 74
Animal testing has long been integral to the development of biologicals, including vaccines. The use of animals can provide important information on potential toxicity, insights into their mechanism of action, pharmacokinetics and dynamics, physiolog
Autor:
Vivian W. Doelling, Warren Casey, Sue Nelson, Dorothy Xing, Brett Jones, Jean-Michel Chapsal, William S. Stokes, Christina Bache, Marlies Halder, Catherine S. Sprankle, Lori Rinckel, Richard McFarland, Amélie Castiaux, Angele Costanzo, Richard Isbrucker, Nelson W Johnson, Juan Arciniega, Marieke Hoonakker
Publikováno v:
Biologicals. 42:114-122
Regulatory authorities require safety and potency testing prior to the release of each production lot of acellular pertussis (aP)-containing vaccines. Currently, the murine histamine sensitization test (HIST) is used to evaluate the presence of resid
Autor:
David Allen, Dorothea Sesardic, Michael P. Schmitt, Yoshinobu Horiuchi, Paul Stickings, Johan Descamps, Warren Casey, Daniela Verthelyi, Richard Isbrucker, Elizabeth A. Lipscomb, Nelson W Johnson, Juan Arciniega, Richard McFarland, Theresa M. Finn
Publikováno v:
Procedia in Vaccinology
NICEATM and ICCVAM convened an international workshop to review the state of the science of human and veterinary vaccine potency and safety testing methods, and to identify opportunities to advance new and improved methods that can further reduce, re
Autor:
Abebaw Diress, Xuguang Li, Louise Larocque, Richard Isbrucker, Barry Lorbetskie, Michel Girard, Matthew Alteen
Publikováno v:
Journal of Chromatography A. 1217:3297-3306
Interferon alpha-2 (IFN alpha-2) products have been widely used as antivirals for the treatment of serious diseases such as hepatitis B and C. However, reports of adverse reactions following treatment have prompted investigations into the cause of th
Publikováno v:
Vaccine. 28:2687-2692
A binding assay was recently published that differentiates between pertussis toxin (PTx) and the pertussis toxoid (PTd) used in acellular pertussis vaccines based on the selective binding of PTx to fetuin and detection with a polyclonal antibody. We
Autor:
Ursula Bonifas, Heike A. Behrensdorf-Nicol, Hans-Peter Ottiger, Beate Krämer, Kay-Martin Hanschmann, Rob Tierney, Karin Weisser, Richard Isbrucker
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 42(4)
Tetanus vaccines contain detoxified tetanus neurotoxin. In order to check for residual toxicity, the detoxified material (toxoid) has to be tested in guinea pigs. These tests are time-consuming and raise animal welfare issues. In line with the "3R" p
Autor:
Richard Isbrucker, Ban C. H. Tsui, Alastair E. Cribb, Terry L. LeVatte, C. T. Gillespie, Kenneth W. Renton
Publikováno v:
Scopus-Elsevier
Eighteen healthy Caucasians were evaluated for the systemic acetylation of a caffeine metabolite using the urinary caffeine metabolite ratio 5-acetylamino-6-formylamino-3-methyluracil (AFMU) to 1-methylaxanthine (1X) and for N-acetyltransferase activ
Publikováno v:
Procedia in Vaccinology. :147-150
Health Canada (HC) is Canada's national regulatory body that oversees the review, authorization, and lot (batch) release of human vaccines. All biologic drugs, including vaccines, are subject to the Biologics and Genetic Therapies Directorate's Lot R